MBG Presents the Drug Discovery Fall Seminar Series: “The Biotechnology Edge”
Dr. Lakshman Ramamurthy (Senior Director & Head of CDX Global Regulatory, GlaxoSmithKline Inc.) will continue our series with a discussion on Regulatory Strategy.
Next-Gen Sequencing Diagnostics for Precision Medicine – Regulatory Update
Cancer is a disease of the genome. Next-generation sequencing has proven a valuable key to unlocking targeted therapies. FoundationOne CDx has been great advance in precision oncology and immunotherapy.
Please RSVP HERE to help us plan. Refreshments will be provided. Thursday, Dec 5, 4:30-5:30 in room 4-231.